Polyclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
| Code | Size | Price |
|---|
| PAA133Mu01-20ul | 20ul | £71.00 |
Quantity:
| PAA133Mu01-100ul | 100ul | £125.00 |
Quantity:
| PAA133Mu01-200ul | 200ul | £165.00 |
Quantity:
| PAA133Mu01-1ml | 1ml | £368.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Mouse
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
DIF; TNF-A; TNFSF2; Cachectin; Tumor Necrosis Factor Ligand Superfamily Member 2
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Tumor Necrosis Factor Alpha
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.01-2ug/mL
Immunohistochemistry: 5-40ug/mL
Immunocytochemistry: 5-40ug/mL
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-40ug/mL
Immunocytochemistry: 5-40ug/mL
Optimal working dilutions must be determined by end user.
References
https://www.ncbi.nlm.nih.gov/pubmed/32528295; https://pubmed.ncbi.nlm.nih.gov/32764579/;
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Tumor Necrosis Factor Alpha (TNFa) | RPA133Mu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||